| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Non-Hodgkin LymphomasPayerPolicy · BSCA-HCT-Non-Hodgkin-Lymphomas | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsPayerPolicy · BSCA-HCT-Miscellaneous-Solid-Tumors-Adults | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · BSCA-HCT-Hodgkin-Lymphoma | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Epithelial Ovarian CancerPayerPolicy · BSCA-HCT-Epithelial-Ovarian-Cancer | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Chronic Myeloid LeukemiaPayerPolicy · BSCA-HCT-Chronic-Myeloid-Leukemia | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPayerPolicy · BSCA-HCT-Chronic-Lymphocytic-Leukemia-Small-Lymphocytic-Lymphoma | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and EpendymomaPayerPolicy · BSCA-HCT-Central-Nervous-System-Embryonal-Tumors-Ependymoma | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Autoimmune DiseasesPayerPolicy · BSCA-HCT-Autoimmune-Diseases | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · BSCA-HCT-Acute-Myeloid-Leukemia | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · BSCA-HCT-Acute-Lymphoblastic-Leukemia | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Heart/Lung TransplantPayerPolicy · BSCA-Heart-Lung-Transplant | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Heart TransplantPayerPolicy · BSCA-Heart-Transplant | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving SurgeryPayerPolicy · BSCA-Handheld-Radiofrequency-Spectroscopy-Breast-Conserving-Surgery | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2)PayerPolicy · BSCA-Germline-Genetic-Test-Breast-Ovarian-Cancer-BRCA1-BRCA2-PALB2 | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for the Diagnosis of Inherited Peripheral NeuropathiesPayerPolicy · BSCA-Genetic-Testing-Dx-Inherited-Peripheral-Neuropathies | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Statin-Induced MyopathyPayerPolicy · BSCA-Genetic-Test-Statin-Induced-Myopathy | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Predisposition to Inherited Hypertrophic CardiomyopathyPayerPolicy · BSCA-Genetic-Testing-Predispo-Inherited-Hypertrophic-Cardiomyopathy | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Mitochondrial DisordersPayerPolicy · BSCA-Genetic-Testing-Mitochondrial-Disorders | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related DisordersPayerPolicy · BSCA-Genetic-Test-Marfan-Syndrome-Thoracic-Aneurysms-Dissections | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Macular DegenerationPayerPolicy · BSCA-Genetic-Testing-Macular-Degeneration | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer SyndromesPayerPolicy · BSCA-Genetic-Testing-Lynch-Syndrome-Inherited-Colon-Cancer-Syndromes | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Idiopathic Dilated CardiomyopathyPayerPolicy · BSCA-Genetic-Testing-Idiopathic-Dilated-Cardiomyopathy | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Heterozygous Familial HypercholesterolemiaPayerPolicy · BSCA-Genetic-Test-Heterozygous-Familial-Hypercholesterolemia | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Hereditary Hearing LossPayerPolicy · BSCA-Genetic-Test-Hereditary-Hearing-Loss | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for FMR1 Variants (Including Fragile X Syndrome)PayerPolicy · BSCA-Genetic-Test-FMR1-Variants-Including-Fragile-X-Syndrome | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for EpilepsyPayerPolicy · BSCA-Genetic-Testing-Epilepsy | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Duchenne and Becker Muscular DystrophyPayerPolicy · BSCA-Genetic-Test-Duchenne-Becker-Muscular-Dystrophy | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Diagnosis and Management of Mental Health ConditionsPayerPolicy · BSCA-Genetic-Testing-Dx-Management-Mental-Health-Conditions | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital AnomaliesPayerPolicy · BSCA-Genetic-Testing-Dev-Delay-Autism-Spectrum-Congenital-Anomalies | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Cardiac Ion ChannelopathiesPayerPolicy · BSCA-Genetic-Testing-Cardiac-Ion-Channelopathies | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Testing for Alzheimer DiseasePayerPolicy · BSCA-Genetic-Testing-Alzheimer-Disease | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Cancer Susceptibility Panels Using Next-Generation SequencingPayerPolicy · BSCA-Genetic-Cancer-Susceptibility-Panels-Using-Next-Gen-Sequencing | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Advanced CancerPayerPolicy · BSCA-Genetic-Biomarker-Testing-TX-Advanced-Cancer | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate CancerPayerPolicy · BSCA-Genetic-Protein-Biomarkers-Dx-Cancer-Risk-Prostate-Cancer | New policy |
|---|
| May 13, 2026 | Blue Shield of California | General Approach to Genetic TestingPayerPolicy · BSCA-General-Approach-Genetic-Testing | New policy |
|---|
| May 13, 2026 | Blue Shield of California | General Approach to Evaluating the Utility of Genetic PanelsPayerPolicy · BSCA-General-Approach-Evaluating-Utility-Genetic-Panels | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Gene Expression Profiling, Protein Biomarkers, and Multimodal Artificial Intelligence for Prostate Cancer ManagementPayerPolicy · BSCA-Gene-Expression-Profiling-Protein-Biomarkers-Prostate-Cancer | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Gene Expression Profiling for Cutaneous MelanomaPayerPolicy · BSCA-Gene-Express-Profiling-Cutaneous-Melanoma | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon CancerPayerPolicy · BSCA-Gene-Express-Profile-Test-Circulating-Tumor-DNA-Colon-Cancer | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Gender Affirmation SurgeryPayerPolicy · BSCA-Gender-Affirmation-Surgery | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Gastric Electrical StimulationPayerPolicy · BSCA-Gastric-Electrical-Stimulation | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Functional Neuromuscular Electrical StimulationPayerPolicy · BSCA-Functional-Neuromuscular-Electrical-Stimulation | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Functional Endoscopic Sinus Surgery for Chronic RhinosinusitisPayerPolicy · BSCA-Functional-Endoscopic-Sinus-Surgery-Chronic-Rhinosinusitis | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Fractional Carbon Dioxide (CO2) Laser Ablation Treatment of Hypertrophic Scars or KeloidsPayerPolicy · BSCA-Fractional-CO2-Laser-Ablation-TX-Hypertrophic-Scars | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Focal Treatments for Prostate CancerPayerPolicy · BSCA-Focal-Treatments-Prostate-Cancer | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Fecal Microbiota TransplantationPayerPolicy · BSCA-Fecal-Microbiota-Transplantation | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Fecal Calprotectin TestingPayerPolicy · BSCA-Fecal-Calprotectin-Testing | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Fecal Analysis in the Diagnosis of Intestinal DysbiosisPayerPolicy · BSCA-Fecal-Analysis-DX-Intestinal-Dysbiosis | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Facet ArthroplastyPayerPolicy · BSCA-Facet-Arthroplasty | New policy |
|---|
| May 13, 2026 | Blue Shield of California | Eyelid Thermal Pulsation for the Treatment of Dry Eye SyndromePayerPolicy · BSCA-Eyelid-Thermal-Pulsation-TX-Dry-Eye-Syndrome | New policy |
|---|